Please assess the completion status of the following clinical trial:

Trial Title: Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults who have Fontan repair of single ventricle~Exclusion Criteria: Persons with the following history, conditions, or behavior will be excluded~* Active protein losing enteropathy within the past three years~* Congestive heart failure~* Active arrhythmias~* Taking Coumadin (Warfarin)~* Bleeding disorder~* Known esophageal varicies~* Consuming more than 10 alcoholic drinks per week.~* Pregnant~* Planning to become pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention: aspirin (Type: EXPERIMENTAL): 650 mg. Twice a day for 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).